Owning to the rapid advances in imaging techniques and particularly tyrosine kinase inhibitors (TKIs) for patients harboring epidermal growth factor receptor (EGFR) mutations, recent years saw increasing incidence of LM from NSCLC [3]. Here, EGFR is linked to non-small cell lung carcinoma.